Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes, Allan Glanville, Peter A B Wark, Philip J. Thompson, Paul Hernandez, Jan Chlumsky, Helmut Teschler, Joachim H. Ficker, Niels Seersholm, Alan Altraja, Riitta Mäkitaro, Joanna Chorostowska-Wynimko, Marek Sanak, Paul I. Stoicescu, Eeva Piitulainen, Oliver Vit, Marion Wencker, Michael A. TortoriciMichael Fries, Jonathan M. Edelman, Kenneth R. Chapman, RAPID Extension Trial Group

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)'. Together they form a unique fingerprint.

Medicine & Life Sciences